Clinical Trial Update: Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics/pharmacodynamics, and preliminary anti-tumor activity of RO7122290 in combination with cibisatamab with obinut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cibisatamab (cibisatamab)
• Obinutuzumab (obinutuzumab)
• RO7122290

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED